Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Inflamm Bowel Dis. 2013 Mar-Apr;19(4):779–784. doi: 10.1097/MIB.0b013e3182802b0e

Table 1.

Baseline characteristics of enrolled cohort (N=149)

Mean Age in yrs (SEM) 37 (2)
Male (%) 50
Mean Disease Duration in yrs (SEM) 21 (2)
Clinical Remission > 6 months (%) 81
Steroid use in last 12 months (%) 13
Disease geography
 Left-sided colitis (%) 52
 Extensive colitis (%) 48
Current medications
 Mesalamine (%) 76
 Azathioprine / mercaptopurine (%) 18
 Infliximab (%) 6
Laboratory Markers (SEM)
 WCC (K/uL) 6.3 (2)
 Hematocrit (%) 41 (0.4)
 ESR (mm/hr) 11 (1)
 CRP (mg/L) 3.6 (0.4)